Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study-Reference-Cited by-同舟云学术

Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study

Published:2023-05-04 Issue:5 Volume:62 Page:480-487
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Vanaken Lize¹^ORCID,Woei-A-Jin F.J. Sherida H.¹^ORCID,Van Ginderdeuren Rita²³^ORCID,Deroose Christophe M.⁴^ORCID,Laenen Annouschka⁵^ORCID,Missotten Guy²,Thal Dietmar R.³⁶^ORCID,Bechter Oliver¹^ORCID,Schöffski Patrick¹^ORCID,Clement Paul¹

Affiliation:

1. Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium

2. Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium

3. Department of Pathology, University Hospitals Leuven, Leuven, Belgium

4. Department of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium

5. Biostatistics and Statistical Bioinformatics Center, Leuven, Belgium

6. Laboratory of Neuropathology, Department of Imaging and Pathology and Leuven Brain Institute, KU-Leuven, Leuven, Belgium

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2211206

Reference30 articles.

1. Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

2. National Organization for Rare Disorders. Rarediseases.org [Internet]. Ocular melanoma. 2018. https://rarediseases.org/rare-diseases/ocular-melanoma

3. Metastatic uveal melanoma: The final frontier

4. Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extended survival in a case of metastatic choroidal melanoma with immunotherapy;Anti-Cancer Drugs;2024-07-30

2. Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma;Journal for ImmunoTherapy of Cancer;2024-06